Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

February

28

ATEC Announces Agreement To Acquire EOS Imaging

Accelerates revenue by creating significant pull-through and cross-selling opportunities via an expanded sales network...

18

Exagen to Present at Cowen and Company 40th Annual Healthcare Conference

Live webcast and replay links will be available from the investor relations section of...

27

electroCore, Inc. Announces Rebate Agreement with Ascent Health Services for gammaCore Preferred Brand Coverage on all Express Scripts Standard National Formularies

Agreement opens reimbursement pathway for thousands of patients with migraine and cluster headache BASKING...

13

TriSalus™ Life Sciences Launches the new TriNav™ Infusion System, an Innovative Solution Designed to Overcome Infusion Barriers within Solid Tumors

Engineered for Improved Selectivity in Complex Vasculature1 January 13, 2020 — DENVER–(BUSINESS WIRE)–TriSalusTM Life Sciences (“TriSalus”),...

10

OrthoSensor and McLaren Applied Announce New Business Venture

Strategic collaboration will see expanded development of wearable smart technology MOTIONSENSE™ and data analytics...

27

electroCore Announces Board of Directors Transition

Michael Atieh to assume chairmanship effective April 1, 2020 December 27, 2019 at 10:06...

16

Exagen Announces Addition to Russell 3000® and 2000® Indexes

Inclusion takes effect at market opening on December 23, 2019 SAN DIEGO, Dec. 16, 2019 (GLOBE...

10

National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board

Members include Dr. Arthur Weinstein, Dr. Joel Kremer, Dr. Anca Askanase, Dr. Andrew Concoff, Dr. Maureen McMahon, and Dr. Vasileios...

3

NICE Recommends the Use of gammaCore for the Treatment of Cluster Headache in the NHS

NICE has today published a medical technologies guidance document recommending the use of gammaCore...

26

ATEC Announces Commercial Launch Of The SafeOp Neural InformatiX System™

Automated Technology Detects Location and Monitors Health of Nerves During Spine Surgery CARLSBAD, Calif., Nov....

25

UCB Announces availability of NAYZILAM® (midazolam) Nasal Spray CIV, the first and only nasal rescue treatment for seizure clusters in the U.S.

Available in retail pharmacies on December 2, 2019. Copay support and a patient assistance...

22

Exagen Extends Agreement with GSK for a Third Year

Continued collaboration to drive greater awareness about challenges facing lupus diagnosis and management SAN...

Recent developments

News

February

28

ATEC Announces Agreement To Acquire EOS Imaging

February

18

Exagen to Present at Cowen and Company 40th Annual Healthcare Conference

January

27

electroCore, Inc. Announces Rebate Agreement with Ascent Health Services for gammaCore Preferred Brand Coverage on all Express Scripts Standard National Formularies

January

13

TriSalus™ Life Sciences Launches the new TriNav™ Infusion System, an Innovative Solution Designed to Overcome Infusion Barriers within Solid Tumors

January

10

OrthoSensor and McLaren Applied Announce New Business Venture

December

27

electroCore Announces Board of Directors Transition

December

16

Exagen Announces Addition to Russell 3000® and 2000® Indexes

December

10

National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board

December

3

NICE Recommends the Use of gammaCore for the Treatment of Cluster Headache in the NHS

November

26

ATEC Announces Commercial Launch Of The SafeOp Neural InformatiX System™

November

25

UCB Announces availability of NAYZILAM® (midazolam) Nasal Spray CIV, the first and only nasal rescue treatment for seizure clusters in the U.S.

November

22

Exagen Extends Agreement with GSK for a Third Year